What's new

Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 6, Status: Authorised

Jun 4, 2025 - 16:20
 0
Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (p...

Next Article

Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Da...

Related Posts

Orphan designation: Resminostat Treatment of Hodgkin's lymphoma, 09/12/2011 Withdrawn

Orphan designation: Resminostat Treatment of Hodgkin's ...

Jun 5, 2025  0

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0

Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Date of authorisation: 05/11/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

May 27, 2025  0